Tumor surveillance by circulating microRNAs: A hypothesis

Cellular and Molecular Life Sciences

Volumn 71, Issue 21, 2014, Pages 4081-4087

  Igaz, Ivan ^a   Igaz, Peter ^b  

^a Szent Imre Hospital   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Elimination; Microvesicle; Nascent tumor; Reprogramming

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 150; MICRORNA 202; MICRORNA 20A; MICRORNA 21; MICRORNA 221; MICRORNA 223; MICRORNA 25; MICRORNA 302D; MICRORNA 380; MICRORNA 451; MICRORNA 486; MICRORNA 504; MICRORNA 544; MICRORNA 550; MICRORNA 551A; MICRORNA 622; MICRORNA 623; MICRORNA LET 7A; MICRORNA LET 7G; RNA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD LEVEL; CANCER INHIBITION; CARCINOGENESIS; DISEASE ASSOCIATION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HEMATOPOIESIS; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; TUMOR SUPPRESSOR GENE; BIOLOGICAL MODEL; BLOOD; GENETICS; IMMUNOLOGY; MICROCIRCULATION; NEOPLASM;

GENES, TUMOR SUPPRESSOR; HUMANS; MICROCIRCULATION; MICRORNAS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 84922009394     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1682-4     Document Type: Article

References (53)

1. Alvarez-Garcia I, Miska EA (2005) MicroRNA functions in animal development and human disease. Development 132(21):4653-4662. doi: 10.1242/dev.02073
2. Malumbres M (2013) miRNAs and cancer: an epigenetics view. Mol Aspects Med 34(4):863-874. doi: 10.1016/j.mam.2012.06.005
3. Chen CZ (2005) MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353(17):1768-1771. doi: 10.1056/NEJMp058190
4. Aqeilan RI, Calin GA, Croce CM (2010) miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 17(2):215-220. doi: 10.1038/cdd.2009.69
5. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME (2010) The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 17(1):F19-F36. doi: 10.1677/erc-09-0184
6. Osada H, Takahashi T (2011) Let-7 and miR-17-92: small-sized major players in lung cancer development. Cancer Sci 102(1):9-17. doi: 10.1111/j.1349-7006.2010.01707.x
7. Hong L, Han Y, Zhang Y, Zhang H, Zhao Q, Wu K, Fan D (2013) MicroRNA-21: a therapeutic target for reversing drug resistance in cancer. Expert Opin Ther Targets 17(9):1073-1080. doi: 10.1517/14728222.2013.819853
8. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, Bentwich Z, Hod M, Goren Y, Chajut A (2008) Serum microRNAs are promising novel biomarkers. PLoS ONE 3(9):e3148. doi: 10.1371/journal.pone.0003148
9. Reid G, Kirschner MB, van Zandwijk N (2011) Circulating microRNAs: association with disease and potential use as biomarkers. Crit Rev Oncol/Hematol 80(2):193-208. doi: 10.1016/j.critrevonc.2010.11.004
10. Redis RS, Calin S, Yang Y, You MJ, Calin GA (2012) Cell-to-cell miRNA transfer: from body homeostasis to therapy. Pharmacol Ther 136(2):169-174. doi: 10.1016/j.pharmthera.2012.08.003
11. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, Tait JF, Tewari M (2012) Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prevent Res (Philadelphia, Pa) 5(3):492-497. doi: 10.1158/1940-6207.capr-11-0370
12. Chen G, Wang J, Cui Q (2013) Could circulating miRNAs contribute to cancer therapy? Trends Mol Med 19(2):71-73. doi: 10.1016/j.molmed.2012.10.006
13. Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D, Musolino C (2012) Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Int J Oncol 41(6):1897-1912. doi: 10.3892/ijo.2012.1647
14. Jarry J, Schadendorf D, Greenwood C, Spatz A, van Kempen LC (2014) The validity of circulating microRNAs in oncology: five years of challenges and contradictions. Mol Oncol. doi: 10.1016/j.molonc.2014.02.009
15. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA (2011) MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 8(8):467-477. doi: 10.1038/nrclinonc.2011.76
16. Taylor DD, Gercel-Taylor C (2013) The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids. Front Genet 4:142. doi: 10.3389/fgene.2013.00142
17. Ma R, Jiang T, Kang X (2012) Circulating microRNAs in cancer: origin, function and application. J Exp Clin Cancer Res 31:38. doi: 10.1186/1756-9966-31-38
18. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18(10):997-1006. doi: 10.1038/cr.2008.282
19. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513-10518. doi: 10.1073/pnas.0804549105
20. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, Nana-Sinkam SP, Jarjoura D, Marsh CB (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 3(11):e3694. doi: 10.1371/journal.pone.0003694
21. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56(11):1733-1741. doi: 10.1373/clinchem.2010.147405
22. Szabo DR, Luconi M, Szabo PM, Toth M, Szucs N, Horanyi J, Nagy Z, Mannelli M, Patocs A, Racz K, Igaz P (2014) Analysis of circulating microRNAs in adrenocortical tumors. Lab Invest J Tech Methods Pathol 94(3):331-339. doi: 10.1038/labinvest.2013.148
23. Liu D, Liu C, Wang X, Ingvarsson S, Chen H (2014) MicroRNA-451 suppresses tumor cell growth by down-regulating IL6R gene expression. Cancer Epidemiol 38(1):85-92. doi: 10.1016/j.canep.2013.12.005
24. Godlewski J, Bronisz A, Nowicki MO, Chiocca EA, Lawler S (2010) microRNA-451: A conditional switch controlling glioma cell proliferation and migration. Cell cycle (Georgetown, Tex) 9(14):2742-2748. doi: 10.4161/cc.9.14.12248
25. Bitarte N, Bandres E, Boni V, Zarate R, Rodriguez J, Gonzalez-Huarriz M, Lopez I, JavierSola J, Alonso MM, Fortes P, Garcia-Foncillas J (2011) MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem cells (Dayton, Ohio) 29(11):1661-1671. doi: 10.1002/stem.741
26. Namlos HM, Meza-Zepeda LA, Baroy T, Ostensen IH, Kresse SH, Kuijjer ML, Serra M, Burger H, Cleton-Jansen AM, Myklebost O (2012) Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS ONE 7(10):e48086. doi: 10.1371/journal.pone.0048086
27. Gits CM, van Kuijk PF, Jonkers MB, Boersma AW, Smid M, van Ijcken WF, Coindre JM, Chibon F, Verhoef C, Mathijssen RH, den Bakker MA, Verweij J, Sleijfer S, Wiemer EA (2013) MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors. Int J Cancer. doi: 10.1002/ijc.28694
28. Xu H, Mei Q, Shi L, Lu J, Zhao J, Fu Q (2013) Tumor-suppressing effects of miR451 in human osteosarcoma. Cell Biochem Biophys. doi: 10.1007/s12013-013-9783-5
29. Haneklaus M, Gerlic M, O'Neill LA, Masters SL (2013) miR-223: infection, inflammation and cancer. J Intern Med 274(3):215-226. doi: 10.1111/joim.12099
30. Nian W, Ao X, Wu Y, Huang Y, Shao J, Wang Y, Chen Z, Chen F, Wang D (2013) miR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2. Oncol Lett 6(2):359-366. doi: 10.3892/ol.2013.1375
31. Glasgow SM, Laug D, Brawley VS, Zhang Z, Corder A, Yin Z, Wong ST, Li XN, Foster AE, Ahmed N, Deneen B (2013) The miR-223/nuclear factor I-A axis regulates glial precursor proliferation and tumorigenesis in the CNS. J Neurosci 33(33):13560-13568. doi: 10.1523/jneurosci.0321-13.2013
32. Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, Kuroda M (2009) Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS ONE 4(5):e5532. doi: 10.1371/journal.pone.0005532
33. Zhao LY, Yao Y, Han J, Yang J, Wang XF, Tong DD, Song TS, Huang C, Shao Y (2014) miR-638 suppresses cell proliferation in gastric cancer by targeting Sp2. Dig Dis Sci. doi: 10.1007/s10620-014-3087-5
34. Sun Z, Zhang Z, Liu Z, Qiu B, Liu K, Dong G (2014) MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2. Med Oncol (Northwood, London, England) 31(6):982. doi: 10.1007/s12032-014-0982-8
35. Li H, Xie S, Liu M, Chen Z, Liu X, Wang L, Li D, Zhou Y (2014) The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. Int J Oncol 45(1):197-208. doi: 10.3892/ijo.2014.2415
36. Cao J, Cai J, Huang D, Han Q, Yang Q, Li T, Ding H, Wang Z (2013) miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w. Oncol Rep 30(2):701-706. doi: 10.3892/or.2013.2482
37. Wang Y, Zhao W, Fu Q (2013) miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells. Mol Cell Biochem 384(1-2):105-111. doi: 10.1007/s11010-013-1786-4
38. Formosa A, Markert EK, Lena AM, Italiano D, Finazzi-Agro E, Levine AJ, Bernardini S, Garabadgiu AV, Melino G, Candi E (2013) MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene. doi: 10.1038/onc.2013.451
39. Tahiri A, Leivonen SK, Luders T, Steinfeld I, Ragle Aure M, Geisler J, Makela R, Nord S, Riis ML, Yakhini Z, Kleivi Sahlberg K, Borresen-Dale AL, Perala M, Bukholm IR, Kristensen VN (2014) Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors. Carcinogenesis 35(1):76-85. doi: 10.1093/carcin/bgt333
40. Wang J, Tian X, Han R, Zhang X, Wang X, Shen H, Xue L, Liu Y, Yan X, Shen J, Mannoor K, Deepak J, Donahue JM, Stass SA, Xing L, Jiang F (2014) Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene 33(9):1181-1189. doi: 10.1038/onc.2013.42
41. Zhu DX, Zhu W, Fang C, Fan L, Zou ZJ, Wang YH, Liu P, Hong M, Miao KR, Liu P, Xu W, Li JY (2012) miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. Carcinogenesis 33(7):1294-1301. doi: 10.1093/carcin/bgs179
42. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3(11):991-998. doi: 10.1038/ni1102-991
43. Hamai A, Benlalam H, Meslin F, Hasmim M, Carre T, Akalay I, Janji B, Berchem G, Noman MZ, Chouaib S (2010) Immune surveillance of human cancer: if the cytotoxic T-lymphocytes play the music, does the tumoral system call the tune? Tissue Antigens 75(1):1-8. doi: 10.1111/j.1399-0039.2009.01401.x
44. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646-674. doi: 10.1016/j.cell.2011.02.013
45. Finn NA, Searles CD (2012) Intracellular and Extracellular miRNAs in Regulation of Angiogenesis Signaling. Curr Angiogenesis 4(102):299-307. doi: 10.2174/2211552811201040299
46. Rayner KJ, Hennessy EJ (2013) Extracellular communication via microRNA: lipid particles have a new message. J Lipid Res 54(5):1174-1181. doi: 10.1194/jlr.R034991
47. Zhang L, Hou D, Chen X, Li D, Zhu L, Zhang Y, Li J, Bian Z, Liang X, Cai X, Yin Y, Wang C, Zhang T, Zhu D, Zhang D, Xu J, Chen Q, Ba Y, Liu J, Wang Q, Chen J, Wang J, Wang M, Zhang Q, Zhang J, Zen K, Zhang CY (2012) Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res 22(1):107-126. doi: 10.1038/cr.2011.158
48. Etheridge A, Gomes CP, Pereira RW, Galas D, Wang K (2013) The complexity, function and applications of RNA in circulation. Front Genet 4:115. doi: 10.3389/fgene.2013.00115
49. Snow JW, Hale AE, Isaacs SK, Baggish AL, Chan SY (2013) Ineffective delivery of diet-derived microRNAs to recipient animal organisms. RNA Biol 10(7):1107-1116. doi: 10.4161/rna.24909
50. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341-345. doi: 10.1038/nbt.1807
51. Takahashi K, Yokota S, Tatsumi N, Fukami T, Yokoi T, Nakajima M (2013) Cigarette smoking substantially alters plasma microRNA profiles in healthy subjects. Toxicol Appl Pharmacol 272(1):154-160. doi: 10.1016/j.taap.2013.05.018
52. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, Brummelkamp TR, Fleming MD, Camargo FD (2008) Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451(7182):1125-1129. doi: 10.1038/nature06607
53. Patrick DM, Zhang CC, Tao Y, Yao H, Qi X, Schwartz RJ, Jun-Shen Huang L, Olson EN (2010) Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3zeta. Genes Dev 24(15):1614-1619. doi: 10.1101/gad.1942810